Join us Thursday evening November 14, 2019 at 7:00 pm CST!
5:00 pm PST…6:00 pm MST…7:00 pm CST…8:00 pm EST
Listen live (HERE)
Call in # 917-388-4520
Hosted by Marti Oakley with Arlene Mullin
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Whistleblower’s is presented in coordination with Marcel Reid and the Annual Whistleblower’s Summit in Washington D.C.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Join Marti Oakley and Arlene Mullin as we expose more of the dialysis industry and the danger the current system represents to dialysis patients. Joining us this evening is Dr. David Moskowitz, MD.
Our guest: David W. Moskowitz, MD
- – Chairman, Chief Executive Officer, and Chief Medical Officer, and Founder of GenoMed, Inc. (GenoMed.com) Dr. Moskowitz majored in Chemistry (summa cum laude) at Harvard College, Biochemistry (first class honours) at Merton College, Oxford, and received an MD (cum laude) from the Harvard-MIT Division in Health Sciences and Technology (Harvard Medical School). He trained for 7 years in Internal Medicine, Biochemistry, and Nephrology at Washington University School of Medicine in St. Louis before spending 11 years on the faculty of St. Louis University School of Medicine. Since 1994, Dr. Moskowitz has experienced first hand the clinical effectiveness of knowing a disease-associated gene (the angiotensin converting enzyme, or ACE, gene). Dr. Moskowitz is a pioneer in the field of medical genomics, and has been recognized for his groundbreaking treatment of diseases associated with the angiotensin I-converting enzyme, such as chronic renal failure due to hypertension or type II diabetes.
The PPJ Gazette 
Leave a Reply